Breaking News Instant updates and real-time market news.

AGLE

Aeglea BioTherapeutics

$10.36

0.68 (7.02%)

07:54
04/13/18
04/13
07:54
04/13/18
07:54

Aeglea BioTherapeutics price target raised to $20 from $12 at Needham

Needham analyst Chad Messer raised his price target on Aeglea BioTherapeutics to $20 after the company's Phase 1/2 study presentation for pegzilarginase in Arginase 1 Deficiency at the American College of Medical Genetics and Genomics meeting. Messer points to "significant improvements in multiple parameters" for 2 patients after they completed just 8 weeks of dosing, which should "substantially de-risk" the ARG1-D program going forward. The analyst expects a multi-dose readout in Q3 and a pivotal study design to be completed by the end of this year while forecasting a commercial launch in late 2020. Messer also keeps his Buy rating on Aeglea BioTherapeutics.

  • 21

    May

AGLE Aeglea BioTherapeutics
$10.36

0.68 (7.02%)

03/14/18
BMOC
03/14/18
NO CHANGE
Target $18
BMOC
Outperform
Aeglea BioTherapeutics price target lowered to $18 from $21 at BMO Capital
BMO Capital analyst M. Ian Somaiya lowered his price target on Aeglea BioTherapeutics to $18, updating his model to reflect the cash burn associated with the Phase 3 trial of ARG1-D. The analyst keeps his Outperform rating after the latest data in two patients showed a "near normalization of arginine levels (as) the magnitude of these reductions has never been achieved before using conventional diet-control/ammonia scavengers" method. Somaiya looks ahead to the company's April 12th presentation on ARG1-D at the ACMG Annual Clinical Genetics Meeting.
03/14/18
NEED
03/14/18
NO CHANGE
Target $12
NEED
Buy
Aeglea BioTherapeutics price target raised to $12 from $8 at Needham
Needham analyst Chad Messer raised his price target on Aeglea BioTherapeutics to $12 after the company's presentation on ARG1-D at the annual SIMD meeting that showed two adult patients dosed for 8 weeks demonstrate sustained reductions of arginine at or near normal levels. Messer keeps his Buy rating, stating that the company's $50M in cash is sufficient to reach Q3 of 2019 and get past the full multi-dose data and Phase III trial design, while also noting progress in Aeglea's oncology program.
04/13/18
WELS
04/13/18
NO CHANGE
WELS
Outperform
Wells Fargo increasingly confident on Aeglea's pegzilarginase
Wells Fargo analyst Jim Birchenough reiterates an Outperform rating on shares of Aeglea BioTherapeutics following a call with senior management. The analyst has increased confidence on pegzilarginase's clinical results and the potential positive implications for a de-risked regulatory path. He continues to believe that Aeglea's orphan drug opportunity has been underestimated and sees further upside on additional updates expected in the second half of 2018. Birchenough keeps a $24 price target for the shares.

TODAY'S FREE FLY STORIES

08:50
10/15/18
10/15
08:50
10/15/18
08:50
General news
Treasury Action: yields retreated on the damp retail sales print »

Treasury Action: yields…

SCHW

Charles Schwab

$49.02

0.89 (1.85%)

08:49
10/15/18
10/15
08:49
10/15/18
08:49
Earnings
Charles Schwab reports Q3 EPS 65c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

WNC

Wabash

$13.54

-3.24 (-19.31%)

08:48
10/15/18
10/15
08:48
10/15/18
08:48
Recommendations
Wabash analyst commentary  »

Wabash price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

AQ

Aquantia

$11.45

0.13 (1.15%)

08:47
10/15/18
10/15
08:47
10/15/18
08:47
Initiation
Aquantia initiated  »

Aquantia initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

TDOC

Teladoc

$65.99

3.57 (5.72%)

08:46
10/15/18
10/15
08:46
10/15/18
08:46
Recommendations
Teladoc analyst commentary  »

Teladoc price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ACRX

AcelRx

$3.95

(0.00%)

08:45
10/15/18
10/15
08:45
10/15/18
08:45
Recommendations
AcelRx analyst commentary  »

AcelRx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CGC

Canopy Growth

$49.79

2.64 (5.60%)

, CWH

Camping World

$21.37

0.42 (2.00%)

08:45
10/15/18
10/15
08:45
10/15/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

CGC

Canopy Growth

$49.79

2.64 (5.60%)

CWH

Camping World

$21.37

0.42 (2.00%)

BLUE

Bluebird Bio

$125.92

-0.81 (-0.64%)

BGS

B&G Foods

$25.83

-0.16 (-0.62%)

CPB

Campbell Soup

$37.10

-0.05 (-0.13%)

IYT

iShares Transportation Average

$188.69

1.55 (0.83%)

NTR

Nutrien

$54.11

0.05 (0.09%)

SHPG

Shire

$170.37

2.14 (1.27%)

GERN

Geron

$1.69

0.02 (1.20%)

CX

Cemex

$6.23

0.145 (2.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 01

    Dec

  • 21

    Dec

08:45
10/15/18
10/15
08:45
10/15/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

08:45
10/15/18
10/15
08:45
10/15/18
08:45
General news
U.S. October Empire State index rebounded 2.1 ticks to 21.1 »

U.S. October Empire State…

BYD

Boyd Gaming

$31.86

0.13 (0.41%)

, GLPI

Gaming and Leisure Properties

$34.09

0.01 (0.03%)

08:43
10/15/18
10/15
08:43
10/15/18
08:43
Hot Stocks
Boyd Gaming completes acquisition of four Pinnacle Entertainment assets »

Boyd Gaming has completed…

BYD

Boyd Gaming

$31.86

0.13 (0.41%)

GLPI

Gaming and Leisure Properties

$34.09

0.01 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ROK

Rockwell Automation

$172.89

2.3 (1.35%)

08:43
10/15/18
10/15
08:43
10/15/18
08:43
Downgrade
Rockwell Automation rating change  »

Rockwell Automation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$5.41

0.345 (6.82%)

08:43
10/15/18
10/15
08:43
10/15/18
08:43
Recommendations
Vipshop analyst commentary  »

Vipshop price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSI

FTS International

$12.21

0.3 (2.52%)

08:41
10/15/18
10/15
08:41
10/15/18
08:41
Upgrade
FTS International rating change  »

FTS International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

SPY

SPDR S&P 500 ETF Trust

$275.95

3.51 (1.29%)

, SPX

S&P 500

$0.00

(0.00%)

08:41
10/15/18
10/15
08:41
10/15/18
08:41
General news
Trump says Saudi Arabia's King denies knowledge of what happened to journalist »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$275.95

3.51 (1.29%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSC

Harsco

$24.87

-0.24 (-0.96%)

08:40
10/15/18
10/15
08:40
10/15/18
08:40
Hot Stocks
Harsco Rail awarded multiyear MTA contract valued at approx. $40M »

Harsco Corporation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

08:40
10/15/18
10/15
08:40
10/15/18
08:40
General news
U.S. retail sales rose 0.1% in September, and fell 0.1% excluding autos »

U.S. retail sales rose…

KRYS

Krystal Biotech

$15.49

0.58 (3.89%)

08:40
10/15/18
10/15
08:40
10/15/18
08:40
Conference/Events
Krystal Biotech to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

DLGNF

Dialog Semiconductor

$0.00

(0.00%)

08:39
10/15/18
10/15
08:39
10/15/18
08:39
Upgrade
Dialog Semiconductor rating change  »

Dialog Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPI

Gaming and Leisure Properties

$34.09

0.01 (0.03%)

, PENN

Penn National

$29.91

1.33 (4.65%)

08:39
10/15/18
10/15
08:39
10/15/18
08:39
Hot Stocks
Gaming and Leisure enters into master lease with Boyd to include 3 properties »

Gaming and Leisure…

GLPI

Gaming and Leisure Properties

$34.09

0.01 (0.03%)

PENN

Penn National

$29.91

1.33 (4.65%)

PNK

Pinnacle Entertainment

$32.57

0.57 (1.78%)

BYD

Boyd Gaming

$31.86

0.13 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TNDM

TNDM

08:39
10/15/18
10/15
08:39
10/15/18
08:39
Recommendations
TNDM analyst commentary  »

Tandem Diabetes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

NTRI

Nutrisystem

$37.12

1.11 (3.08%)

08:39
10/15/18
10/15
08:39
10/15/18
08:39
Downgrade
Nutrisystem rating change  »

Nutrisystem downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PH

Parker-Hannifin

$167.41

1.71 (1.03%)

08:38
10/15/18
10/15
08:38
10/15/18
08:38
Downgrade
Parker-Hannifin rating change  »

Parker-Hannifin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.82

0.0363 (4.63%)

08:38
10/15/18
10/15
08:38
10/15/18
08:38
Hot Stocks
Matinas BioPharma appoints Theresa Matkovits as CDO »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PENN

Penn National

$29.91

1.33 (4.65%)

, PNK

Pinnacle Entertainment

$32.57

0.57 (1.78%)

08:37
10/15/18
10/15
08:37
10/15/18
08:37
Hot Stocks
Penn National completes acquisition of Pinnacle Entertainment »

Penn National Gaming…

PENN

Penn National

$29.91

1.33 (4.65%)

PNK

Pinnacle Entertainment

$32.57

0.57 (1.78%)

BYD

Boyd Gaming

$31.86

0.13 (0.41%)

GLPI

Gaming and Leisure Properties

$34.09

0.01 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

CUBI

Customers Bancorp

$21.82

-1.01 (-4.42%)

08:37
10/15/18
10/15
08:37
10/15/18
08:37
Upgrade
Customers Bancorp rating change  »

Customers Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 26

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.